Department of Neurosurgery, The General Hospital of Shenyang Military Command, Shenyang, PR China.
Eur J Radiol. 2012 May;81(5):e750-6. doi: 10.1016/j.ejrad.2012.01.036. Epub 2012 Feb 29.
There is a potential risk of aneurysm rupture after parent artery revascularization because of increased blood flow. The purpose of this study is to assess the efficacy and safety of Wingspan stent-assisted coil embolization in the treatment of intracranial aneurysms with symptomatic parent artery stenosis.
Thirty-five consecutive patients (19 men, 16 women; age range, 48-79 years; mean age, 60.4 years) harboring 35 unruptured wide-necked or fusiform intracranial aneurysms (mean size 6.8mm; range 2.5-18 mm.) with symptomatic parent artery stenosis (mean degree 71.1%; range 50-92%) were treated with the Wingspan stent-assisted coiling. Twenty-four lesions were located in the anterior circulation and eleven in the posterior circulation. Patients were premedicated with antiplatelet therapy consisting of aspirin 300 mg and clopidogrel 75 mg for at least 3 days before the procedure. Following pre-dilatation and stent placement, a coiling microcatheter entered the aneurysm through the interstices of the stent, and then coiling was performed. After the procedure, clopidogrel 75 mg daily was recommended for an additional 30 days, and aspirin 100mg was recommended throughout follow-up. For all patients, clinical follow-up was conducted by clinic visitation, or telephone interview. Angiographic follow-up with DSA was recommended at 6 months and 1 year after the procedure. Angiography follow-up (mean time 10.6 months) was obtained in 31 cases (88.6%). The technical feasibility of the procedure, procedure-related complications, angiographic results, clinical outcome and follow-up angiography were evaluated.
In every case, technical success was achieved. The degree of stenosis was reduced from 71.1% to 17.4% after balloon angioplasty and stenting. Immediate angiography demonstrated complete occlusion in 25 cases (71.4%), neck remnant in 7 cases (20.0%), and incomplete occlusion in 3 cases (8.6%). Procedure-related morbidity occurred in two patients (5.7%), including thromboembolism (n=1) and occlusion of small penetrating arteries (n=1). At follow-up (mean time 18.3 months), two additional cases of ischemic stroke occurred. The overall frequency of any stroke, intracranial hemorrhage, or death within 30 days or ipsilateral stroke beyond 30 days was 11.4%. No rehemorrhage of treated aneurysm occurred. At angiographic follow-up, four cases demonstrated ≥ 50% in-stent restenosis (12.9%), one of which was symptomatic, and two aneurysms (6.4% of the follow-up angiograms) demonstrated recanalization.
We found that the Wingspan stent-assisted coil embolization was helpful in the treatment of intracranial aneurysms with parent artery stenosis.
由于血流增加,在进行母动脉血运重建后,动脉瘤破裂的风险可能会增加。本研究的目的是评估 Wingspan 支架辅助弹簧圈栓塞治疗伴有症状性母动脉狭窄的颅内动脉瘤的疗效和安全性。
连续纳入 35 例(男 19 例,女 16 例;年龄 48-79 岁;平均年龄 60.4 岁)伴有症状性母动脉狭窄(狭窄程度 50-92%,平均 71.1%)的 35 个未破裂宽颈或梭形颅内动脉瘤(平均直径 6.8mm;范围 2.5-18mm)的患者,接受 Wingspan 支架辅助弹簧圈栓塞治疗。24 个病变位于前循环,11 个位于后循环。所有患者在术前至少 3 天接受抗血小板治疗,包括阿司匹林 300mg 和氯吡格雷 75mg。预扩张和支架置入后,通过支架的网眼将微导管送入动脉瘤内,然后进行弹簧圈栓塞。术后推荐氯吡格雷 75mg/d 再服用 30 天,阿司匹林 100mg 终身服用。所有患者均通过门诊就诊或电话访谈进行临床随访。建议术后 6 个月和 1 年行 DSA 血管造影随访。31 例(88.6%)获得了血管造影随访(平均时间 10.6 个月)。评估了手术的技术可行性、与手术相关的并发症、血管造影结果、临床结果和随访血管造影。
在每例患者中,均实现了技术成功。球囊血管成形术和支架置入后,狭窄程度从 71.1%降低至 17.4%。即刻血管造影显示 25 例(71.4%)完全闭塞,7 例(20.0%)瘤颈残留,3 例(8.6%)不完全闭塞。2 例患者(5.7%)发生与手术相关的并发症,包括血栓栓塞(n=1)和小穿支动脉闭塞(n=1)。随访(平均时间 18.3 个月)时,另外 2 例发生缺血性卒中。30 天内任何卒中、颅内出血或死亡,或 30 天以上同侧卒中的总发生率为 11.4%。未再发生治疗后动脉瘤出血。血管造影随访时,4 例(12.9%)显示支架内再狭窄≥50%,其中 1 例为症状性,2 个动脉瘤(随访血管造影的 6.4%)显示再通。
我们发现,Wingspan 支架辅助弹簧圈栓塞有助于治疗伴有母动脉狭窄的颅内动脉瘤。